CD8A and leukemia: Collectively, these data indicate that leukemia-primed ST2+ Treg cells kill in vitro and in vivo, via direct contact and a GZMB-mediated lysis of antigen-specific CD8 lymphocytes that have been continuously stimulated by the leukemia.